CXCL1 and breast cancer: Accordingly, the inhibition of NF-κB blocks CXCL1-induced SOX4 overexpression, increases the E-cadherin and reduces both vimentin and β-catenin expression, underlying the importance of CXCL1/SOX4/NF-κB axis in sustaining breast cancer [114].